For citations:
Nedogoda S.V., Chumachek E.V., Tsoma V.V., Sanina T.N., Salasyuk A.S., Smirnova V.O., Popova E.A. Azilsartan medoxomil for improving insulin resistance and adipokine levels in hypertension in comparison with angiotensin-converting enzyme inhibitors. Russian Journal of Cardiology. 2020;25(7):3767. (In Russ.) https://doi.org/10.15829/1560-4071-2020-3767